Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Synthetic Long Stock trade opportunity for CLOVIS ONCOLOGY (CLVS) for the 15-Jan-2021 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. CLVS was recently trading at $11.84 and has an implied volatility of 73.56% for this period. Based on an analysis of the options available for CLVS expiring on 15-Jan-2021, there is a 68.27% likelihood that the underlying will close within the analyzed range of $4.04-$36.20 at expiration. In this scenario, the average linear return for the trade would be 69.61%. Upside potential: This synthetic long position offers the same potential benefits and liabilities as a long stock position, but at a discount due to the significant premium at-the-money puts are trading at over calls. In this case, the put position is opened at a strike of $13.00, which is already $1.17 in-the-money. However, its sale more than offsets this moneyness and the cost of the long call that the trade results in a net credit of of $2.90 per share. The final position can be considered as having a discount of $1.74 per share over the underlying price of $11.84 for a 14.66% total. Downside risk: This discount is generally a sign of the stock facing considerable short pressure, and may indicate that the stock has become hard to borrow. However, if you have a long view of the underlying over this period, it could be a good opportunity to benefit from the upside at a major discount. To analyze this trade in depth, please visit the Quantcha Options Search Engine.